LYXUMIA

This brand name is authorized in Austria, Brazil, Cyprus, Estonia, Finland, Hong Kong SAR China, Ireland, Japan, Lithuania, Netherlands, Poland, Romania, Singapore, Spain, Turkey, UK.

Active ingredients

The drug LYXUMIA contains one active pharmaceutical ingredient (API):

1	Lixisenatide UNII 74O62BB01U - LIXISENATIDE
	Lixisenatide is a selective GLP-1 receptor agonist. The GLP-1 receptor is the target for native GLP-1, an endogenous incretin hormone that potentiates glucose-dependent insulin secretion from the pancreatic beta cells. Lixisenatide stimulates insulin secretion when blood glucose is increased but not at normoglycaemia, which limits the risk of hypoglycaemia. In parallel, glucagon secretion is suppressed. In case of hypoglycaemia, the rescue mechanism of glucagon secretion is preserved.
	Read more about Lixisenatide

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
LYXUMIA Solution for injection	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A10BJ03		A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BJ Glucagon-like peptide-1 (GLP-1) analogues
Discover more medicines within A10BJ03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	502813120065802, 502813120066002, 576720080085017, 576720080085117
EE	Ravimiamet	1607206, 1607217, 1607228, 1607239, 1607240
ES	Centro de información online de medicamentos de la AEMPS	12811001, 12811003
FI	Lääkealan turvallisuus- ja kehittämiskeskus	376568, 464765
GB	Medicines & Healthcare Products Regulatory Agency	219411, 219413, 219416, 219538
HK	Department of Health Drug Office	62767
JP	医薬品医療機器総合機構	2499415G1024
LT	Valstybinė vaistų kontrolės tarnyba	1069321, 1069353, 1069354, 1069355, 1069356
NL	Z-Index G-Standaard, PRK	117854, 117862
PL	Rejestru Produktów Leczniczych	100040433, 100292821, 100292838
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W59971001, W59971002, W59971003
SG	Health Sciences Authority	14653P, 14654P, 14655P
TR	İlaç ve Tıbbi Cihaz Kurumu	8699809950818, 8699809950825, 8699809950832, 8699809950849